Vojo Vukovic - 12 Feb 2024 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Hoffman, Attorney-in-Fact
Issuer symbol
DCTH
Transactions as of
12 Feb 2024
Transactions value $
$0
Form type
4
Filing time
14 Feb 2024, 16:46:51 UTC
Previous filing
14 Dec 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCTH Stock Option (Right to Buy) Award $0 +100,500 $0 100,500 12 Feb 2024 Common Stock 100,500 $4.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).